Envestnet Asset Management
PTGX icon

Envestnet Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Envestnet Asset Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
16,317
+1,644
+11% +$146K ﹤0.01% 3112
2025
Q4 		$1.28M Sell
14,673
-9,585
-40% -$785K ﹤0.01% 3131
2025
Q3 		$1.61M Buy
24,258
+380
+2% +$21.6K ﹤0.01% 3020
2025
Q2 		$1.32M Buy
23,878
+7,199
+43% +$346K ﹤0.01% 3098
2025
Q1 		$807K Buy
16,679
+7,698
+86% +$323K ﹤0.01% 3339
2024
Q4 		$347K Sell
8,981
-3,802
-30% -$166K ﹤0.01% 3813
2024
Q3 		$575K Sell
12,783
-776
-6% -$31.4K ﹤0.01% 3468
2024
Q2 		$470K Buy
13,559
+2,390
+21% +$70K ﹤0.01% 3494
2024
Q1 		$323K Buy
+11,169
New +$304K ﹤0.01% 3686

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return